Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria
© Chowdhury et al.; licensee Springer. 2014
Received: 17 April 2014
Accepted: 19 July 2014
Published: 26 July 2014
In recent years, green synthesis of nanoparticles, i.e., synthesizing nanoparticles using biological sources like bacteria, algae, fungus, or plant extracts have attracted much attention due to its environment-friendly and economic aspects. The present study demonstrates an eco-friendly and low-cost method of biosynthesis of silver nanoparticles using cell-free filtrate of phytopathogenic fungus Macrophomina phaseolina. UV-visible spectrum showed a peak at 450 nm corresponding to the plasmon absorbance of silver nanoparticles. Scanning electron microscopy (SEM), atomic force microscopy (AFM), and transmission electron microscopy (TEM) revealed the presence of spherical silver nanoparticles of the size range 5 to 40 nm, most of these being 16 to 20 nm in diameter. X-ray diffraction (XRD) spectrum of the nanoparticles exhibited 2θ values corresponding to silver nanoparticles. These nanoparticles were found to be naturally protein coated. SDS-PAGE analysis showed the presence of an 85-kDa protein band responsible for capping and stabilization of the silver nanoparticles. Antimicrobial activities of the silver nanoparticles against human as well as plant pathogenic multidrug-resistant bacteria were assayed. The particles showed inhibitory effect on the growth kinetics of human and plant bacteria. Furthermore, the genotoxic potential of the silver nanoparticles with increasing concentrations was evaluated by DNA fragmentation studies using plasmid DNA.
KeywordsGreen synthesis Macrophomina phaseolina Silver nanoparticles Antimicrobial Capping DNA fragmentation
The production, manipulation, and application of nanoscale particles, usually ranging from 1 to 100 nanometers (nm), is an emerging area of science and technology today . Synthesis of noble metal nanoparticles for applications in catalysis, electronics, optics, environmental science, and biotechnology is an area of constant interest . Generally, metal nanoparticles can be prepared and stabilized by physical and chemical methods. Studies have shown that the size, morphology, stability, and physicochemical properties of the metal nanoparticles are strongly influenced by the experimental conditions, the kinetics of interaction of metal ions with reducing agents, and adsorption processes of stabilizing agent with metal nanoparticles . Chemical approaches, such as chemical reduction, electrochemical techniques, and photochemical reduction, are most widely used . Recently, different solvothermal  and hydrothermal  approaches are employed for inorganic synthesis of nanoparticles. Chemical reduction is the most frequently applied method for the preparation of silver nanoparticles as stable, colloidal dispersions in water or organic solvents . However, several harmful chemical by-products, metallic aerosol, irradiation, etc. are commonly produced during chemical synthesis processes. These, along with the facts that these processes are expensive, time consuming, and typically done on small laboratory scale, render these methods less suitable for large-scale production [7–9]. The approach for production of nanoparticles therefore should be nontoxic, environmentally harmless, as well as cost effective .
For green synthesis of nanoparticles, bio-extracts from diverse group of microorganisms act as a reducing and sometimes as a capping agent in nanoparticle synthesis, ranging from algae  to bacteria  and also from fungi . For large-scale synthesis of nanoparticles in bioreactors, filamentous fungi are better agents for biomass production in comparison to algae and bacteria, since fungal mycelial mat can withstand flow pressure, agitation, and other conditions in the bioreactors . Extracellular secretion of reductive proteins aids in extracellular synthesis of silver nanoparticles avoiding unnecessary cellular interference, and therefore, it is suitable for direct use in various applications. There are reports of mycosynthesis of silver nanoparticles using phytopathogenic fungi like Fusarium acuminatum, Aspergillus flavus, Alternaria alternata, Coriolus versicolor, Penicillium fellutanum, and Fusarium semitectum. Some fungi investigated were found to be capable of both extra- and intracellular biosynthesis of Ag-NPs having different particle sizes and shapes, but extracellular production of nanoparticles is more desirable from the point of view of easy isolation.
Nanoparticles have some unique size- and shape-dependent physical and optical properties . These unique characters are often responsible for their toxicity to various kinds of microbes such as bacteria, fungi, and also cancerous cells [20–22]. Hence, studies are going on regarding their utility in the diagnosis as well as treatment of different kinds of diseases [23, 24]. In this regard, the presence of protein capping material is advantageous because this acts as the anchoring layer for drug or genetic materials to be transported into human cells . The presence of a nontoxic protein cap also increases uptake and retention inside human cells .
The present study deals with the extracellular biosynthesis of silver nanoparticles, using cell-free extract of phytopathogenic soil-borne fungus Macrophomina phaseolina (Tassi) Goid, the causal organism of charcoal rot disease of about 500 agronomical important crops all over the world . It describes not only a new method of green synthesis of silver nanoparticles but also their physical attributes, antibacterial activity against human and plant pathogenic multidrug-resistant bacteria, the inhibitory effect on the growth kinetics of microbes, the capping material around the silver nanoparticles, as well as their genotoxic effect.
M. phaseolina was grown in PDA medium at 28°C and was used for the synthesis of silver nanoparticles. The mycelium from solid substrate was inoculated in 50 ml potato dextrose broth (PDB) in 250-ml Erlenmeyer flasks and incubated at 28°C for 5 days. The fully expanded mycelial mat was harvested aseptically and washed with sterile distilled water to remove media components. One gram of washed mat was added to 10 ml of deionized water in a 250-ml Erlenmeyer flask and agitated at 28°C for 72 h in an orbital shaker at 120 rpm. The extract was collected and filtered through Whatman filter paper No. 1 (Whatman, Piscataway, NJ, USA). This cell-free filtrate was used for nanoparticle synthesis. The biosynthesis of silver nanoparticles was done by adding silver nitrate (AgNO3) solution to 50-ml cell filtrate to a final concentration of 1 mM in a 250-ml Erlenmeyer flask and agitating in a shaker at 120 rpm at 28°C in the dark for 24, 48, and 72 h. A control set without silver nitrate was simultaneously agitated with experimental set . The silver nanoparticle synthesis was visible by distinct change in coloration of cell filtrate.
The qualitative testing for confirmation of silver nanoparticles was done with UV–vis spectroscopy. One milliliter of sample aliquot from this bio-transformed product was drawn after 24, 48, and 72 h postincubation with silver nitrate solution, and absorbance was recorded by using Hitachi U-2000 spectrophotometer (Hitachi, Ltd., Chiyoda-ku, Japan) range between 350 and 600 nm in order to study the change in light absorption of the solution with increase in color intensity.
About 20 μl of silver nanoparticle solution was spread as a thin film on a glass stub (1 cm × 1 cm) and was vacuum dried. The sample was subjected to scanning electron microscopy using FEI Quanta 200 (FEI, Hillsboro, OR, USA). The average size and shapes of the silver nanoparticles were determined by transmission electron microscopy (TEM). A drop of nanoparticles suspension was placed on a carbon-coated copper grid and was dried under vacuum. Micrographs were obtained in a JEOL JEM 2100 HR transmission electron microscope (JEOL Ltd., Akishima-shi, Japan) with 80- to 200-kV accelerating voltage at 0.23-nm resolution. For atomic force microscopy (AFM) imaging of silver nanoparticles, 10 μl of the nanoparticle suspension was deposited onto a freshly cleaved muscovite Ruby mica sheet (Ruby Mica Co. Ltd., Jharkhand, India) and left to stand for 15 to 30 min. The sample was subsequently dried by using a vacuum dryer and washed with 0.5 ml Milli-Q water (Millipore, Billerica, MA, USA). The sheets were dried again by a vacuum dryer. The size and topography of silver nanoparticles were investigated using atomic force microscope (Model Innova, Bruker AXS Pvt. Ltd, Madison, WI, USA) under tapping mode in which high-resolution surface images were produced. Microfabricated silicon cantilevers of 135-μm length and 8-nm diameter with a nominal spring force constant of 20 to 80 N/m were used. The cantilever resonance frequency was 276 to 318 kHz. The deflection signal is analyzed in the NanoScope IIIa controller (Bruker AXS Pvt. Ltd.), and the images (512 × 512 pixels) were captured with a scan size range of 0.5 and 5 μm.
For X-ray diffraction (XRD) of silver nanoparticles, a thin film of nanoparticle solution was spread evenly on a glass slide and dried by using vacuum dryer. XRD patterns were recorded in a D8 Advance DAVINCI XRD System (Bruker AXS Pvt. Ltd.) operated at a voltage of 40 kV and a current of 40 mA with CuKα radiation (λ = 1.54060/1.54443 Å), and the diffracted intensities were recorded from 35° to 80° 2θ angles.
The multidrug-resistant strains of Escherichia coli (DH5α) and Agrobacterium tumefaciens (LBA4404) were prepared according to previous report from our lab . The DH5α-multidrug-resistant (MDR) strain (containing plasmids pUC19 and pZPY112) was selected against antibiotics ampicillin (100 μg/ml) and chloramphenicol (35 μg/ml). LBA4404-MDR containing plasmid pCAMBIA 2301 was selected against antibiotics rifampicin (25 mg/l) and kanamycin (50 mg/l). LB broth/agar were used to culture the bacteria. The disc diffusion method was employed for assaying antimicrobial activities of biosynthesized silver nanoparticles against E. coli (DH5α), multidrug-resistant E. coli (DH5α-MDR), plant pathogenic bacteria A. tumefaciens (LBA4404), and multidrug-resistant A. tumefaciens (LBA4404-MDR). One hundred microliters of overnight cultures of each bacterium was spread onto LB agar plates. Concentration of nanoparticles in suspension was calculated according to  following the formula [where C = molar concentration of the nanoparticles solution, T = total number of silver atoms added as AgNO3 (1 mM), N = number of atoms per nanoparticles, V = volume of reaction solution in liters, and A = Avogadro’s number (6.023 × 1,023)]. The concentration of silver nanoparticles was found to be 51 mg/l. This silver nanoparticle suspension was used in requisite amount for further antimicrobial study. Sterile paper discs of 5-mm diameter with increasing percentage of silver nanoparticles in a total volume of 100 μl (volume made up with sterile double distilled water) were placed on each plate. Ten, 20, 50, 70, and 100% silver nanoparticle solution corresponding to 0.51, 1.02, 2.55, 3.57, and 5.1 μg of silver nanoparticles in 100-μl solution each were placed on the discs. Plates inoculated with A. tumefaciens (LBA4404 and LBA4404-MDR) were incubated in 28°C for 48 h, and those inoculated with strains of E. coli (DH5α and DH5α-MDR) were kept at 37°C for 12 h. Antimicrobial activity of silver nanoparticles was assessed by measuring inhibition zones around the discs.
In order to observe the effect of the silver nanoparticles on growth kinetics of bacteria, silver nanoparticles were added to the liquid culture of two bacteria, E. coli (DH5α) and A. tumefaciens (LBA4404). For the initial culture, 7 ml of LB medium was inoculated with 500 μl of overnight grown bacterial culture. This freshly set bacterial culture was supplemented with 2.5 ml of nanoparticle suspension, with concentration of 51 μg/ml. In each of the control sets, 2.5 ml of Macrophomina cell filtrate only was added without nanoparticles. The OD values of the mixture was recorded at 600-nm wavelength of visible light at regular time intervals (i.e., 0, 2, 4, 6, 8, 12, and 24 h postinoculation) to plot the growth curves of each of the nanoparticle-treated bacterial cultures and was compared with that of the untreated control.
For isolation of extracellular proteins, about 500 mg of fungal mycelial mat was taken in a microcentrifuge tube, and 500 μl of sterile deionized water was added. The mixture was inverted two to three times for even dispersion of fungal tissue in water. The mixture was gently agitated overnight at 4°C on a shaker. The next day, the slurry was centrifuged at 10,000 rpm for 10 min at 4°C. The cell-free filtrate containing the extracellular proteins was analyzed by one-dimensional SDS-PAGE. In order to isolate the protein(s) bound to the surface of silver nanoparticles, the particles were washed with sterile distilled water and boiled with 1% sodium dodecyl sulfate (SDS) solution for 10 min followed by centrifugation at 8,000 rpm for 10 min for collection of supernatant. The untreated nanoparticles (without boiling in 1% SDS solution) were kept as control. All the other samples were denatured in 2× Laemmli’s sample buffer and boiled for 5 to 10 min, followed by centrifugation at 8,000 rpm at 4°C for 3 min. Electrophoresis was performed in a 12% SDS-polyacrylamide gel using Bio-Rad Mini-PROTEAN gel system (Bio-Rad, Hercules, CA, USA) at a constant voltage of 100 kV for 2 h. Postelectrophoresis, gel was stained with Coomassie Brilliant Blue dye and observed in a gel-imaging system (Chromous Biotech, Bangalore, India).
Genotoxic potential of the silver nanoparticles was tested against plasmid pZPY112 according to [29, 30], with minor modifications. Plasmid was isolated from DH5α (containing pZPY112 vector, selected against rifampicin 50 mg/l and chloramphenicol 40 mg/l) by alkaline lysis method. Five micrograms of plasmid was incubated with 0.51, 1.02, 2.55, 3.57, and 5.1 μg of silver nanoparticle (in a total volume of 100 μl solution) in 1 mM Tris (pH = 7.8) for a period of 2 h at 37°C. In control set, cell filtrate was used instead of the nanoparticle solution. Products were run on a 1.5% agarose gel in 1× TAE buffer at 100 V for 45 min and visualized by ethidium bromide staining. Photographs were taken in an UV-transilluminator (Biostep, Jahnsdorf, Germany).
For antimicrobial disc diffusion assay of silver nanoparticles against bacteria, each bar represents mean of three experiments ± standard error of mean (SEM). Differences between treatments (concentration of nanoparticles) in antimicrobial assay were tested using one-way ANOVA (GraphPad Prism, version 5, La Jolla, CA, USA) followed by Tukey’s honestly significant difference (HSD) test, for differences that were significant at 5% probability.
Results and discussion
Biosynthesis of silver nanoparticles from cell-free filtrate of Macrophomina phaseolina
UV–vis spectroscopy of the silver nanoparticles
The silver nanoparticles were subjected to spectral analysis by UV–vis spectroscopy. The absorption spectra of nanoparticles showed symmetric single-band absorption with peak maximum at 450 nm for 24, 48, and 72 h of incubation of cell filtrate with AgNO3 which steadily increased in intensity as a function of time of reaction without any shift in the peak (Figure 1b). This indicates the presence of silver nanoparticles, showing the longitudinal excitation of surface plasmon, typical of silver nanoparticles.
Morphological study of the silver nanoparticles with scanning electron microscopy
Transmission electron microscopy study of silver nanoparticles
Transmission electron microscopy (TEM) micrographs showed that particles are spherical, uniformly distributed without any significant aggregation (Figure 2b,c,d). Some of the nanoparticles showed striations (Figure 2d). The particle size histogram of silver nanoparticles showed that particle size ranges from 3.33 to 40.15 nm with an average size of 17.26 ± 1.87 nm. Frequency distribution observed from histogram showed that majority of particles (30.82%) lie within the range of 16 to 20 nm (Figure 2e). These silver nanoparticles are especially small and polydisperse in nature. This small size range of silver nanoparticles adds to its antibacterial property, since it can easily penetrate bacterial cell membrane and thereafter damage the respiratory chain, affect the DNA, RNA, and division of the cell, and finally lead to cell death .
Morphological study using atomic force microscopy
The shape and size of the silver nanoparticles were further confirmed by atomic force microscopy (AFM). Majority of the particles were symmetrical and spherical in shape and mostly dispersed; although in some places, nanoparticles were found to be in aggregates (Figure S1 in Additional file 1). The graph depicting the profile of the particles under AFM shows most particles were less than 50 nm in height (Figure S1 in Additional file 1).
X-ray diffraction analysis of silver nanoparticles
Antimicrobial activity of silver nanoparticles against human and plant pathogenic bacteria and multidrug-resistant bacteria
All the four microbes tested (DH5α, DH5α-MDR, LBA4404, LBA4404-MDR) against silver nanoparticles were inhibited significantly (P = 0.05) in a dose-dependent manner. The antimicrobial activity exhibited by silver nanoparticles is shown in the graph of inhibition zone of four bacteria as a function of increasing concentration of nanoparticles (Figures 4 and 5). In general, both E. coli (DH5α) and multidrug-resistant E. coli (DH5α-MDR) showed greater sensitivity to silver nanoparticles than A. tumefaciens (LBA4404 and LBA4404 MDR). Although, the exact mechanism by which silver nanoparticles act as antimicrobial agent is not fully understood, there are several theories. Silver nanoparticles can anchor onto bacterial cell wall and, with subsequent penetration, perforate the cell membrane (pitting of cell membrane) ultimately leading to cell death . The dissipation of the proton motive force of the membrane in E. coli occurs when nanomoles concentration of silver nanoparticles is given . Earlier studies with electron spin resonance spectroscopy revealed that free radicals are produced by silver nanoparticles in contact with bacteria, which damage cell membrane by making it porous, ultimately leading to cell death . Antimicrobial activities of silver nanoparticles from other fungal sources like F. semitectum and Aspergillus niger gave similar observations. A previous study from our laboratory  reported similar antimicrobial activities of silver nanoparticles from Tricholoma crassum against human and plant pathogenic bacteria.
Effect of the silver nanoparticles on the kinetics of microbial growth
Analysis of capping protein around the silver nanoparticles
Genotoxic effect of silver nanoparticles against plasmid DNA
In this study, phytopathogenic fungus M. phaseolina (Tassi) Goid was used for the first time for the extracellular biosynthesis of silver nanoparticles by bioreduction of aqueous Ag + ion. SEM, TEM, and AFM were used to study the morphology, concentration, and size of biosynthesized nanoparticles. The silver nanoparticles exhibited distinct antimicrobial property on multidrug-resistant human and plant pathogenic bacteria. An 85-kDa protein present in the extracellular solution was responsible for synthesis and capping of nanoparticles. This eco-friendly, cost-effective extracellular biosynthesis of naturally protein-capped silver nanoparticles with potent antimicrobial activities from the phytopathogenic fungus has the potential to be utilized on a large scale for widespread industrial or medical application.
This work was partially supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (DBT). SC is thankful to University Grants Commission (UGC-NET), New Delhi, and AB is thankful to the Council for Scientific and Industrial Research (CSIR-NET), New Delhi for providing senior research fellowship. We also thank the AFM facility of DBT-IPLS, Center for Modern Biology, University of Calcutta and transmission electron microscope facility of Center for Research in Nanoscience and Nanotechnology (CRNN), University of Calcutta, XRD facility of Central Glass and Ceramics Research Institute, Kolkata, and the Scanning Electron Microscope facility, Bose Institute, Kolkata.
- Mohanpuria P, Nisha K, Rana NK, Yadav SK: Biosynthesis of nanoparticles: technological concepts and future applications. J Nanopart Res 2008, 10: 507–517.View ArticleGoogle Scholar
- Sharma VK, Yngard RE, Lin Y: Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 2009, 145: 83–96.View ArticleGoogle Scholar
- Knoll B, Keilmann F: Near-field probing of vibrational absorption for chemical microscopy. Nature 1999, 399: 134–137.View ArticleGoogle Scholar
- Gao G, Huang P, Zhang Y, Wang K, Qin W, Cui D: Gram scale synthesis of super paramagnetic Fe3O4 nanoparticles and fluid via a facile solvothermal route. Cryst Eng Comm 2011, 13: 1782–1785.View ArticleGoogle Scholar
- Gao G, Wang K, Huang P, Zhang Y, Zhi X, Bao C, Cui D: Superparamagnetic Fe3O4–Ag hybrid nanocrystals as a potential contrast agent for CT imaging. Cryst Eng Comm 2012, 14: 7556–7559.View ArticleGoogle Scholar
- Wiley B, Sun Y, Mayers B: Shape-controlled synthesis of metal nanostructures: the case of silver. Chemistry 2005, 11: 454–463.View ArticleGoogle Scholar
- Mansoori GA: Principles of Nanotechnology—Molecular-Based Study of Condensed Matter in Small Systems. New Jersey: World Scientific Publishing Company; 2005.View ArticleGoogle Scholar
- Elumalai EK, Prasad TNVKV, Kambala V, Nagajyothi PC, David E: Green synthesis of silver nanoparticle using Euphorbia hirta L and their antifungal activities. Arch Appl Sci Res 2010, 2: 76–81.Google Scholar
- Sahu M, Biswas P: Size distributions of aerosols in an indoor environment with engineered nanoparticle synthesis reactors operating under different scenarios. J Nanopart Res 2010, 12: 1055–1064.View ArticleGoogle Scholar
- Sudha SS, Rajamanickam K, Rengaramanujam J: Microalgae mediated synthesis of silver nanoparticles and their antibacterial activity against pathogenic bacteria. Ind J Expt Biol 2013, 51: 393–399.Google Scholar
- Ganeshkumar C, Mamidyala SK: Extracellular synthesis of silver nanoparticles using culture supernatant of Pseudomonas aeruginosa . Colloids Surf B: Biointerfaces 2011, 84: 462–466.View ArticleGoogle Scholar
- Vahabi K, Mansoori GA, Karimi S: Biosynthesis of silver nanoparticles by fungus Trichoderma reesei (a route for large-scale production of AgNPs). Insci J 2011, 1: 65–79.View ArticleGoogle Scholar
- Ingle AP, Gade AK, Pierrat S, Sönnichsen C, Rai MK: Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci 2008, 4: 141–144.View ArticleGoogle Scholar
- Jain N, Bhargava A, Majumdar S, Tarafdar JC, Panwar J: Extracellular biosynthesis and characterization of silver nanoparticles using Aspergillus flavus NJP08: a mechanism perspective. Nanoscale 2011, 3: 635–641.View ArticleGoogle Scholar
- Ouda SM: Antifungal activity of silver and copper nanoparticles on two plant pathogens, Alternaria alternata and Botrytis cinerea . Res J Microbiol 2014, 9: 34–42.View ArticleGoogle Scholar
- Sanghi R, Verma P: Biomimetic synthesis and characterization of protein capped silver nanoparticles. Biores Technol 2009, 100: 501–504.View ArticleGoogle Scholar
- Kathiresan KS, Manivannan SMA, Nabeel MAB, Dhivya B: Studies on silver nanoparticles synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove sediment. Colloids Surf B: Biointerfaces 2009, 71: 133–137.View ArticleGoogle Scholar
- Basavaraja S, Balaji SD, Lagashetty A, Rajasab AH, Venkataraman A: Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium semitectum . Mater Res Bull 2008, 43: 1164–1170.View ArticleGoogle Scholar
- Rayford CE II, Schatz G, Shuford K: Optical properties of gold nanospheres. Nanoscape 2005, 2: 27–33.Google Scholar
- Duran N, Marcato PD, De S, Gabriel IH, Alves OL, Esposito E: Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J Biomed Nanotechnol 2007, 3: 203–208.View ArticleGoogle Scholar
- Shamsaie A, Jonczyk M, Sturgis J, Robinson JP, Irudayaraj J: Intracellularly grown gold nanoparticles as potential surface-enhanced Raman scattering probes. J Biomed Optics 2007, 12: 020502.View ArticleGoogle Scholar
- Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venkateshan R: Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine 2010, 6: 103–109.View ArticleGoogle Scholar
- El-Sayed IH, Huang X, El-Sayed MA: Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nanoletters 2005, 5: 829–834.View ArticleGoogle Scholar
- Singh M, Singh S, Prasad S, Gambhir IS: Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig J Nanomater Biostruct 2008, 3: 115–122.Google Scholar
- Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L: Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. PNAS 2011, 108: 10980–10985.View ArticleGoogle Scholar
- Rodriguez PL, Harada T, Christian DA, Patano DA, Tsai RK, Discher DE: Minimal ‘self’ peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 2013, 339: 971. Doi: 10.1126/science.1229568 Doi: 10.1126/science.1229568View ArticleGoogle Scholar
- Islam MS, Haque MS, Islam MM, Emdad EM, Halim A, Hossen QM, Hossain MZ, Ahmed B, Rahim S, Raahman MS, Alam MM, Hou S, Wan X, Saito JA, Alam M: Tools to kill: genome of one of the most destructive plant pathogenic fungi Macrophomina phaseolina . BMC Genomics 2013, 13: 493.View ArticleGoogle Scholar
- Ray S, Sarkar S, Kundu S: Extracellular biosynthesis of silver nanoparticles using the mycorrhizal mushroom Tricholoma crassum (Berk.) Sacc: its antimicrobial activity against pathogenic bacteria and fungus, including multidrug resistant plant and human bacteria. Dig J Nanomater Biostruc 2011, 6: 1289–1299.Google Scholar
- Sriram MI, Kanth SBM, Kalishwarlal K, Gurunathan S: Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int J Nanomed 2010, 5: 753–762.Google Scholar
- Jose GP, Santra S, Mandal SK, Sengupta TK: Singlet oxygen mediated DNA degradation by copper nanoparticles: potential towards cytotoxic effect on cancer cells. J Nanobiotechnol 2011, 9: 9.View ArticleGoogle Scholar
- Prabhu S, Poulose EK: Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett 2012, 2: 32.View ArticleGoogle Scholar
- Rai M, Yadav A, Gade A: Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009, 27: 76–83.View ArticleGoogle Scholar
- Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacama MJ: The bactericidal effect of silver nanoparticles. Nanotech 2005, 16: 2346–2353.View ArticleGoogle Scholar
- Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM: Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006, 5: 916–924.View ArticleGoogle Scholar
- Jaidev LR, Narasimha G: Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity. Colloids Surf B: Biointerfaces 2010, 81: 430–433.View ArticleGoogle Scholar
- Chitra K, Annadurai G: Bioengineered silver nanobowls using Trichoderma viride and its antibacterial activity against gram-positive and gram-negative bacteria. J Nanostruct Chem 2013, 3: 9.View ArticleGoogle Scholar
- Lima R, Feitosa LO, Ballottin D, Marcato PD, Tasic L, Duran N: Cytotoxicity and genotoxicity of biogenic silver nanoparticles. J Phys Conf Ser 2013, 429: 012020.View ArticleGoogle Scholar
- Ghosh M, Chakrabarty A, Bandyopadhyay M, Mukherjee A: Multi-walled carbon nanotubes (MWCNT): induction of DNA damage in plant and mammalian cells. J Hazard Mater 2011, 197: 327–336.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.